Fig. 4: Overall survival and progression free survival of patients with respect to IMiD maintenance and CHIP.

a OS and b PFS among patients with CHIP versus those without CHIP in the context of receiving versus not receiving IMiD maintenance post ASCT. Overall and pairwise two-sided log-rank p-values are shown unadjusted for multiple testing.